First report of a healthy Indian heterozygous for Δ32 mutant of HIV-1 co-receptor-CCR5 gene

Gene

Volumn 207, Issue 2, 1998, Pages 141-147

  Husain, Sajid ^a   Goila, Ritu ^a   Shahi, Shweta ^a   Banerjea, Akhil C ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

Genomic DNA mutation; Genotyping; HIV 1 co receptors

Indexed keywords

CHEMOKINE RECEPTOR; COMPLEMENTARY DNA;

ALLELE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INHERITANCE; MAJOR CLINICAL STUDY; MEMBRANE FUSION; MUTANT; POPULATION GENETICS; PRIORITY JOURNAL; REPORTER GENE;

ALLELES; BASE SEQUENCE; CLONING, MOLECULAR; DNA; DNA MUTATIONAL ANALYSIS; DNA, ANTISENSE; FEMALE; GENES, DOMINANT; GENOTYPE; HETEROZYGOTE; HUMANS; INDIA; MOLECULAR SEQUENCE DATA; MUTATION; RECEPTORS, CCR5; SEQUENCE DELETION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032579209     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(97)00617-3     Document Type: Article

References (19)

1. "a" or "b"
2. Banerjea A.C., Brechling K.A., Ray C.A., Erickson H., Pickup D.J., Joklik W.K. High-level synthesis of biologically active reovirus protein σ1 in a mammalian expression vector system. Virology. 167:1988;601-612.
3. Banerjea A.C., Kedarnath N., Gore M.M., Dayaraj C., Jamkar A.V., Ghosh S.N. Interferon (type-α and γ) production by fresh and cryopreserved human mononuclear cells. Arch. Virol. 69:1981;91-94.
4. Banerjea, A. C., Pant, V., Trivedi, J., Harikrishnan, T. A., Husain, S., 1996. Inhibition of HIV-1 Env expression by antisense against envelope regions of HIV-1 using vaccinia virus T7 polymerase system, Abstract # 1635). Xth International Congress of Virology, Jerusalem, Israel, 11-16 August.
5. Biti R., Ffrench R., Young J., Bennetts B., Stewart G. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nature Medicine. 3:1997;252-253.
6. Chen C.-J., Banerjea A.C., Harmison G.G., Haglund K., Schubert M. Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication - potential effectiveness against most presently sequenced HIV-1 isolates. Nucl. Acids Res. 20:1992;4581-4589.
7. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., Goedert J.J., Buchbinder S.P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R., O'Brien S.J. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science. 273:1996;1856-1862.
8. D'Souza M.P., Harden A.V. Chemokines and HIV-1 second receptors. Nature Medicine. 2:1996;1293-1300.
9. Fauci A.S. Host factors and the pathogenesis of HIV-1-induced disease. Nature. 384:1996;529-534.
10. Fuerst T.R., Earl P.L., Moss B. Use of hybrid vaccinia virus -T7 polymerase system for expression of target genes. Mol. Cell. Biol. 7:1987;2538-2544.
11. He J., Chen Y., Farzan M., Choe H., Ohagen A., Gartner S., Busciglio J., Yang X., Hofmann W., Newman W., Mackay R.C., Sodroski J., Gabuzda D. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature. 385:1997;645-649.
12. Huang Y., Paxton W.A., Wolinsky S.M., Neumann A.U., Zhang L., He T., Kang S., Ceradini D., Jin Z., Yazdanbaksh K., Kunstman K., Erickson D., Dragon E., Landau N.R., Phair J., Ho D.D., Koup R.A. The role of mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Medicine. 2:1996;1240-1243.
13. Joklik W.K. The purification of four strains of pox virus. Virology. 18:1962;9-18.
14. Liu R., Paxton W.A., Choe S., Ceradini D., Martin R.S., Horuk R., MacDonald E.M., Stuhlmann H., Koup R.A., Landau N.R. Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply exposed individuals to HIV-1 infection. Cell. 86:1996;367-377.
15. Michael N.L., Chang G., Louie L.L., Mascola J.R., Dondero D., Birx D.L., Sheppard H.W. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Medicine. 3:1997;338-340.
16. Paik S.-Y., Banerjea A.C., Harmison G.G., Chen C.-J., Schubert M. Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein. J. Virol. 69:1995;3529-3537.
17. Rucker J., Samson M., Doranz B.J., Libert F., Berson J.F., Yi Y., Smyth R.J., Collman R.G., Broder C.C., Vassart G., Doms R.W., Parmentier M. Regions in b-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell. 87:1996;437-446.
18. Samson M., Libert F., Doranj B.J., Rucker J., Liesnard C., Farber C.-M., Saragosti S., Lapoumeroulie C., Cognaux J., Forceille C., Muyldermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R.J., Collman R.G., Doms R.W., Vassart G., Parmentier M. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of CCR5 chemokine receptor gene. Nature. 382:1996;722-725.
19. Samson M., Labbe O., Mollereau C., Vassart G., Parmentier M. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry. 35:1996;3362-3367.